310 related articles for article (PubMed ID: 17228221)
1. Review of medications used in juvenile rheumatoid arthritis.
Guthrie B; Rouster-Stevens KA; Reynolds SL
Pediatr Emerg Care; 2007 Jan; 23(1):38-46. PubMed ID: 17228221
[TBL] [Abstract][Full Text] [Related]
2. TNFalpha-blocking agents or conventional immunosuppressive drugs in the therapy of children with uveitis? - an evidence based approach.
Winterhalter S; Niehues T
Klin Padiatr; 2008; 220(6):342-7. PubMed ID: 18949668
[TBL] [Abstract][Full Text] [Related]
3. Juvenile idiopathic arthritis - an update on pharmacotherapy.
Kahn P
Bull NYU Hosp Jt Dis; 2011; 69(3):264-76. PubMed ID: 22035441
[TBL] [Abstract][Full Text] [Related]
4. Juvenile idiopathic arthritis--current and future therapies.
Kahn P
Bull NYU Hosp Jt Dis; 2009; 67(3):291-302. PubMed ID: 19852753
[TBL] [Abstract][Full Text] [Related]
5. Juvenile idiopathic arthritis: some progress but still many uncertainties.
Prescrire Int; 2007 Aug; 16(90):168. PubMed ID: 17724846
[TBL] [Abstract][Full Text] [Related]
6. [Medical treatment of juvenile idiopathic arthritis].
Horneff G; Augustin S
Med Monatsschr Pharm; 2008 Sep; 31(9):326-36; quiz 337-8. PubMed ID: 18831464
[TBL] [Abstract][Full Text] [Related]
7. New advances in the management of juvenile idiopathic arthritis--1: non-biological therapy.
Beresford MW; Baildam EM
Arch Dis Child Educ Pract Ed; 2009 Oct; 94(5):144-50. PubMed ID: 19770494
[TBL] [Abstract][Full Text] [Related]
8. Treatment of juvenile rheumatoid arthritis.
Bloom B
Med Health R I; 1999 Sep; 82(9):329-31. PubMed ID: 10517078
[TBL] [Abstract][Full Text] [Related]
9. Juvenile idiopathic arthritis: a chronic pediatric musculoskeletal condition with significant orofacial manifestations.
Barr T; Carmichael NM; Sándor GK
J Can Dent Assoc; 2008 Nov; 74(9):813-21. PubMed ID: 19000466
[TBL] [Abstract][Full Text] [Related]
10. Update on biologics in juvenile idiopathic arthritis.
Ilowite NT
Curr Opin Rheumatol; 2008 Sep; 20(5):613-8. PubMed ID: 18698187
[TBL] [Abstract][Full Text] [Related]
11. Investigational agents for rheumatoid arthritis.
Merkel PA; Letourneau EN; Polisson RP
Rheum Dis Clin North Am; 1995 Aug; 21(3):779-96. PubMed ID: 8619099
[TBL] [Abstract][Full Text] [Related]
12. Anakinra for systemic juvenile arthritis: the Rocky Mountain experience.
Zeft A; Hollister R; LaFleur B; Sampath P; Soep J; McNally B; Kunkel G; Schlesinger M; Bohnsack J
J Clin Rheumatol; 2009 Jun; 15(4):161-4. PubMed ID: 19363453
[TBL] [Abstract][Full Text] [Related]
13. New therapeutics in rheumatoid arthritis.
Savage C; St Clair EW
Rheum Dis Clin North Am; 2006 Feb; 32(1):57-74, viii. PubMed ID: 16504821
[TBL] [Abstract][Full Text] [Related]
14. Update on treatment of arthritis in children: new treatments, new goals.
Lovell DJ
Bull NYU Hosp Jt Dis; 2006; 64(1-2):72-6. PubMed ID: 17121494
[TBL] [Abstract][Full Text] [Related]
15. Medical treatment of juvenile arthritis.
Fink CW
Clin Orthop Relat Res; 1990 Oct; (259):60-9. PubMed ID: 2208875
[TBL] [Abstract][Full Text] [Related]
16. [Drug therapy of chronic juvenile arthritis].
Tulzer W
Padiatr Padol; 1987; 22(2):199-210. PubMed ID: 3614954
[TBL] [Abstract][Full Text] [Related]
17. [New treatments for idiopathic juvenile arthritis].
Bader-Meunier B; Quartier P
Arch Pediatr; 2009 Dec; 16(12):1607-11. PubMed ID: 19896351
[TBL] [Abstract][Full Text] [Related]
18. [Guidelines in RA treatment: concepts on safety and recommendations using anti-TNF-alpha inhibitors. Grupo de Estudio de Nuevas Terapias de Enfermedades reumáticas (GENTE)].
Díaz-Jouanen E; Abud-Mendoza C; Garza-Elizondo MA; Medrano-Ramírez G; Burgos-Vargas R; Orozco-Alcalá JJ; Pacheco-Tena CF; Pineda C; Pozos-Espíndola JC; Ramos-Niembro F; Robles-San-Román M; Santana-Sahagún JE;
Rev Invest Clin; 2009; 61(3):252-66. PubMed ID: 19736814
[TBL] [Abstract][Full Text] [Related]
19. Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis.
Verbsky JW; White AJ
J Rheumatol; 2004 Oct; 31(10):2071-5. PubMed ID: 15468378
[TBL] [Abstract][Full Text] [Related]
20. Biologic therapies in juvenile idiopathic arthritis: why and for whom?
McCann LJ; Woo P
Acta Reumatol Port; 2007; 32(1):15-26. PubMed ID: 17450761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
